Arca
Skip to content

HCN4: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Hyperpolarization-activated ion channel that are permeable to Na(+) and K(+) ions with very slow activation and inactivation.

  • Drugs that act on it: 2
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
DronedaroneApprovedPotassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blockerBlockerBoxed warning
Ivabradine—Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blockerBlocker—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Sick sinus syndrome 2, autosomal dominant
0.73
Brugada syndrome 8
0.59
Cardiac arrhythmia
0.58
Abnormality of the cardiovascular system
0.52
Familial sick sinus syndrome
0.47
Left ventricular noncompaction cardiomyopathy
0.44
Sinoatrial node disorder
0.43
Congestive heart failure
0.41

Drugs and mechanisms are from ChEMBL CHEMBL1250417 (CC BY-SA 3.0). Gene name, function (UniProt Q9Y3Q4, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.